Home Page
About us
Overview
Organization
Technology
Abiprot
TM
-antibody platform
Abiprot Select
TM
Portfolio
Overview
OT-1096 in TNBC
aTRPV1 & aTRPA1 in pain
aKRAS in colorectal cancer
Collaborations in type 2 diabetes
Corporate Governance
General annual meetings
Board of Directors and Management
Nomination Committee
Investors Relations
Financial Reports
News
Press Releases
Publications, conferences & press
Contact
Oblique Therapeutics
>
News
>
2019
>
March
Home Page
About us
Overview
Organization
Technology
Abiprot
TM
-antibody platform
Abiprot Select
TM
Portfolio
Overview
OT-1096 in TNBC
aTRPV1 & aTRPA1 in pain
aKRAS in colorectal cancer
Collaborations in type 2 diabetes
Corporate Governance
General annual meetings
Board of Directors and Management
Nomination Committee
Investors Relations
Financial Reports
News
Press Releases
Publications, conferences & press
Contact
News
Archive
March 2021
November 2020
October 2020
September 2020
June 2020
November 2019
October 2019
July 2019
March 2019
January 2019
November 2018
October 2018
Categories
Company updates
News
28
Mar
2019
We welcome our new owners
07
Mar
2019
New collaboration with Pharma
